![]() Yale University Dept. of Psychiatry 300 George Street New Haven, CT 06511 USA Tel: 203-785-2117 ![]() |
Department of Psychiatry Faculty
Marina Picciotto, PhDProfessor of Psychiatry Education1985, B.S., Stanford University Research InterestOur goal is to understand the role of single molecules in complex behaviors related to addiction, depression, and learning. We use molecular genetic and pharmacological approaches to link the biochemical, cellular and anatomical levels of investigation to behavior. A primary focus is the role of nicotinic acetylcholine receptors in brain function and development, with a focus on behaviors related to nicotine addiction and smoking. We are also interested in galanin, which is a neuropeptide that protect against the development of addiction. Galanin knockout mice show increased addiction-related behaviors, whereas galanin agonists oppose those behaviors. Finally, we are interested in signaling molecules downstream of nicotinic and galanin receptors, such as calcineurin, CaM kinase I and adducin, that may mediate long-term changes in behavior following receptor activation. Ultimately, integration of studies at the molecular, cellular and systems levels will be necessary to understand the neurobiological basis for expression and plasticity of complex behaviors. Area of ExpertiseMolecular neuroscience Laboratory PersonnelYuki Asaka, Postdoctoral Associate Achievements and Honors
Publications of NoteAddy, N.A., Fornasiero, E. Tanya R Stevens, T.R., Taylor, J.R. and Picciotto, M.R. (2007) Role of calcineurin in nicotine-mediated locomotor sensitization, J Neurosci, 27(32):8571-80. Mineur, Y.S., Somenzi, O. and Picciotto, M.R. (2007) Partial agonists of high affinity nicotinic acetylcholine receptor have antidepressant-like properties in male C57BL/6J mice, Neuropharmacology, 52(5): 1256-62. Uboha, N.V., Flajolet, M., Nairn, A.C. and Picciotto, M.R. (2007) A CaM kinase I/MARK-2 signaling cascade mediates calcium-dependent neurite outgrowth, J Neurosci, 27(16) 4413-23. Rabenstein, R.L., Caldarone, B.J. and Picciotto, M.R. (2006) The nicotinic antagonist mecamylamine has antidepressant-like effects in wild type but not b2 or a7 nicotinic acetylcholine receptor knockout mice. Psychopharmacology, 189(3):395-401. Miwa, J.M., Stevens, T.R., King, S.L., Caldarone, B.J., Ibanez-Tallon, I., Xiao, C., Fitzsimonds, R.M., Pavlides, C., Lester, H.A., Picciotto, M.R. and Heintz, N. (2006) Balancing neuronal activity and survival via the cholinergic modulator lynx1, Neuron, 51(5): 587-600. Staley, J.K., Krishnan-Sarin, S., Cosgrove, K.P., Krantzler, E., Frohlich, E. Perry, E., Dubin, J., Estok, K., Brenner, E., Baldwin, R.M., Tamagnan, G.D., Seibyl, J.P., Jatlow, P., Picciotto, M.R., London, E.D., O’Malley, S. and van Dyck, C.H. (2006) Human tobacco smokers have higher levels of b2* nicotinic acetylcholine receptors during early abstinence. J Neurosci, 26(34):8707-14.
Last modified:
September 25, 2007
|